Endodontic Treatment of Primary Teeth With Guedes-Pinto Paste Without Antibiotic

• Status: Completed
• Trial end date: 2021-04-10
• Target enrollment: 0
• Participant gender: All

Summary

The pulp therapy in primary teeth is still necessary even with all odontopediatrics evolution in prevention and minimal intervention, aiming to keep the tooth free of inflammation or infection and in a functional state until its exfoliation. Several materials are used as filling paste of primary teeth. In Brazil, the Guedes-Pinto Paste (PGP), an association of iodofórmio, camphorated paramonochlorophenol, prednisolone and rifamycin, has been widely used for some decades. However, current Brazilian legislation has made it difficult to commercialize antibiotics, which has made it difficult to obtain the ointment that is the association between prednisolone and rifamycin. Therefore, the objective of this clinical trial will be to test PGP without rifamycin in the pulpectomy of primary teeth, and to compare it with the treatment performed with conventional PGP.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular

Criteria

Inclusion Criteria:

• Primary molar teeth with necessity of endodontic treatment.

• Patients whose parents or guardians consent to their participation in the study

Exclusion Criteria:

• Systemic health problems, congenital facial deformities, facial tumors or syndromes

• Teeth presenting one of the following:

• Resorption of more than 2/3 of the root

• Destruction of the crypt of the permanent successor

• Pulp chamber floor drilling.

• Presence of internal resorption